Literature DB >> 12809884

Cytologic analysis of ureteral washings is informative in patients with grade 2 upper tract TCC considering endoscopic treatment.

A Skolarikos1, T R L Griffiths, P H Powell, D J Thomas, D E Neal, J D Kelly.   

Abstract

OBJECTIVES: To determine the diagnostic accuracy of ureteroscopic biopsy and whether exfoliated cell cytology can improve diagnostic accuracy.
METHODS: Sixty-two cases of upper tract transitional cell carcinoma were diagnosed by ureteroscopic biopsy and treated by nephroureterectomy. Stage and grade evaluation was possible in 51 cases. Cytology for exfoliated cells from the ureter/pelvis was available in 48 cases.
RESULTS: Biopsies were staged as Tis in 3, Ta in 35, and T1 in 13 and graded as G1 in 6, G2 in 32, and G3 in 13. Cytology was positive/suspicious in 40% (19 of 48). The biopsy grade accurately predicted the pathologic grade (P <0.0001) and stage (P = 0.001). The biopsy stage was not associated with the final stage (P = 0.112, Fisher's exact test). Biopsy G3 accurately predicted high-grade (G3) transitional cell carcinoma in 92% (12 of 13) of cases. The remaining 1 case was G2 by final histologic examination. No case of high-grade (G3) disease was found in the 6 G1 biopsies (100%). Of 32 G2 biopsies, 9 were upgraded to G3. Cytology was available for 8 of the 9 and 5 (63%) were positive. For patients with G2 biopsies, combining cytology and biopsy grade improved the sensitivity and specificity of high-grade tumor detection from 43% to 55% and 23% to 85%, respectively.
CONCLUSIONS: The results of this study have shown that biopsy grade reflects the pathologic stage and grade. Combining exfoliated cell cytology improved the predictive power of biopsy G2 disease for high-risk specimen grade. Exfoliated cell cytology in combination with biopsy grade is recommended as part of the evaluation of upper tract transitional cell carcinoma selected for endoscopic management.

Entities:  

Mesh:

Year:  2003        PMID: 12809884     DOI: 10.1016/s0090-4295(03)00026-8

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  14 in total

1.  Upper urinary tract biopsy: an old device for a new approach.

Authors:  G Carrafiello; F Fontana; M Mangini; A M Ierardi; E Cotta; F Piacentino; M De Chiara; C Floridi; A Di Massa; A M Marconi; C Fugazzola
Journal:  Radiol Med       Date:  2012-02-10       Impact factor: 3.469

Review 2.  Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016: treatment of low-risk upper tract urothelial carcinoma.

Authors:  Rao S Mandalapu; Mesut Remzi; Theo M de Reijke; Vitaly Margulis; J Palou; A Kapoor; Ofer Yossepowitch; Jonathan Coleman; Olivier Traxer; J Kyle Anderson; James Catto; Jean de la Rosette; Timothy O'Brien; Anthony Zlotta; Surena F Matin
Journal:  World J Urol       Date:  2016-05-27       Impact factor: 4.226

Review 3.  Risk-adapted strategy for the kidney-sparing management of upper tract tumours.

Authors:  Thomas Seisen; Pierre Colin; Morgan Rouprêt
Journal:  Nat Rev Urol       Date:  2015-02-24       Impact factor: 14.432

4.  Fluorodeoxyglucose positron emission tomography/computed tomography for diagnosis of upper urinary tract urothelial carcinoma.

Authors:  Seiji Asai; Tetsuya Fukumoto; Nozomu Tanji; Noriyoshi Miura; Masao Miyagawa; Kenichi Nishimura; Yutaka Yanagihara; Akitomi Shirato; Yuki Miyauchi; Tadahiko Kikugawa; Masayoshi Yokoyama
Journal:  Int J Clin Oncol       Date:  2015-03-21       Impact factor: 3.402

Review 5.  Perioperative chemotherapy for upper tract urothelial cancer.

Authors:  Ajjai S Alva; Surena F Matin; Seth P Lerner; Arlene O Siefker-Radtke
Journal:  Nat Rev Urol       Date:  2012-04-10       Impact factor: 14.432

6.  Nephroureterectomy for transitional cell carcinoma - the value of pre-operative histology.

Authors:  Sudhanshu Chitale; Rashidi Mbakada; Stuart Irving; Neil Burgess
Journal:  Ann R Coll Surg Engl       Date:  2008-01       Impact factor: 1.891

7.  The significance of functional renal obstruction in predicting pathologic stage of upper tract urothelial carcinoma.

Authors:  Michael J Amirian; Kushan Radadia; Hadley Narins; Kelly A Healy; Scott G Hubosky; Demetrius Bagley; Edouard J Trabulsi; Costas D Lallas
Journal:  J Endourol       Date:  2014-07-16       Impact factor: 2.942

8.  Significance of ureteroscopic biopsy grade in patients with upper tract urothelial carcinoma.

Authors:  Junya Furukawa; Hideaki Miyake; Iori Sakai; Masato Fujisawa
Journal:  Curr Urol       Date:  2012-12-21

9.  Surgical management of upper tract urothelial carcinoma.

Authors:  Vincent G Bird; Prashanth Kanagarajah
Journal:  Indian J Urol       Date:  2011-01

10.  Upper tract urinary cytology to detect upper tract urothelial carcinoma: Using the Johns Hopkins Hospital template and evaluation of its feasibility.

Authors:  Longwen Chen; Huiying He; Matthew A Zarka; Ming Zhou; Cristina Magi-Galluzzi
Journal:  Cytojournal       Date:  2015-07-28       Impact factor: 2.091

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.